ADMA
ADMA Biologics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.62
+0.42%Forward multiples
Based on analyst estimates
- P/E forward
- 11.88x
- P/E 2026E
- 11.99x
- P/E 2027E
- 10.12x
- P/E 2028E
- 7.96x
- P/S forward
- 3.70x
Trailing multiples
Trailing twelve months
- P/E TTM
- 13.36x
- PEG TTM
- 1.06x
- Price / book
- 5.28x
- Price / sales
- 4.21x
- Price / cash flow
- 15.76x
Enterprise value
- Enterprise value
- $2.2B
- EV / sales
- 4.34x
- EV / EBITDA
- 9.46x
- EV / EBIT
- 10.27x
- Market cap
- $2.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026